FDA Approves DAPAGLIFLOZIN — Aurobindo Pharma Limited
Aurobindo Pharma Limited announced the approval of its ANDA for dapagliflozin, granting it rights to manufacture and market this generic oral product by April 2026. This authorizat…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Aurobindo Pharma Limited announced the approval of its ANDA for dapagliflozin, granting it rights to manufacture and market this generic oral product by April 2026. This authorizat…
# FDA Approves Baxter Healthcare's Generic Phenylephrine Hydrochloride Injection Baxter Healthcare Corporation has received FDA approval for its generic phenylephrine hydrochlorid…
# FDA Approves Sandoz's Generic Nintedanib, Expanding Competition in Pulmonary Fibrosis Market Sandoz Inc. has received FDA approval for its generic nintedanib esylate oral formul…
# FDA Approves Dr. Reddy's Laboratories' Generic Nintedanib Dr. Reddy's Laboratories Inc. received FDA approval for its generic nintedanib esylate oral formulation (ANDA219283), m…
# FDA Approves Generic Version of Nintedanib, Enabling Significant Cost Savings for Pulmonary Fibrosis Patients Apotex Corp. has received FDA approval for a generic formulation of…
# FDA Approves Generic Nintedanib Capsules; Exelan Pharmaceuticals Enters Competitive Pulmonary Fibrosis Market Exelan Pharmaceuticals Inc. has received FDA approval for generic n…
Edenbridge Pharmaceuticals LLC has received FDA approval for its ANDA219819 application for Nintedanib Esyslate tablets, strengthening the firm’s portfolio with the generic version…
# FDA Approves Eli Lilly's FOUNDAYO for Oral Administration Eli Lilly and Company received FDA approval for FOUNDAYO (orforglipron calcium), an oral medication that expands the co…
# FDA Approves KLM Laboratories' Generic Mesalamine Rectal Formulation KLM Laboratories Private Limited received FDA approval for its generic mesalamine rectal formulation (ANDA22…
# FDA Approves Generic Olmesartan Medoxomil and Hydrochlorothiazide Combination ScieGen Pharmaceuticals Inc received FDA approval for a generic version of olmesartan medoxomil and…
# FDA Approves Baxter Healthcare's Intramuscular Epinephrine Formulation Baxter Healthcare Corporation received FDA approval for its intramuscular epinephrine formulation (NDA2206…
On March 26, 2026, SAGENT received FDA approval for a new drug, signaling a strategic entry into the market with potential to compete against existing products. The approval is poi…
# FDA Approves Denali Therapeutics' AVLAYAH, Expanding Its Neurology Portfolio Denali Therapeutics Inc. received FDA approval for AVLAYAH (tividenofusp alfa-eknm), an intravenous …
# FDA Approves Generic Mexiletine Hydrochloride from Macleods Pharmaceuticals Macleods Pharmaceuticals Limited has received FDA approval for its generic mexiletine hydrochloride o…
# FDA Approves Aurobindo Pharma's Generic Cefixime Oral Formulation The U.S. FDA has approved Aurobindo Pharma Limited's abbreviated new drug application (ANDA217607) for generic …
# FDA Approves Advagen Pharma's Atomoxetine Hydrochloride for Oral Administration Advagen Pharma Ltd. has received FDA approval for its atomoxetine hydrochloride oral formulation …
# FDA Approves Generic Drug for Fresenius Kabi USA Fresenius Kabi USA received FDA approval for a generic drug formulation under ANDA219991, expanding the company's portfolio in t…
# FDA Approves Generic Drug Application for Actavis Labs FL Inc Actavis Labs FL Inc received FDA approval for abbreviated new drug application (ANDA) 208959 on March 19, 2026, pos…
Septodont Inc. has received FDA approval for the Flavalta submucosal lidocaine and epinephrine system, a launch set for March 19, 2026, which is expected to provide a competitive a…
# FDA Approves Glenmark Therapeutics' Generic Fluticasone Propionate Nasal Spray The FDA has approved Glenmark Therapeutics Inc.'s abbreviated new drug application for generic flu…